Differential antibody response to COVID-19 disease and COVID-19 vaccines
DOI:
https://doi.org/10.18203/2320-6012.ijrms20231595Keywords:
Antibody, COVID-19, Chemiluminescence immunoassay, Immunochromatography, VaccineAbstract
Background: In our study, antibody positivity was evaluated by two methods in vaccinated and unvaccinated people according to their demographic characteristics and history of COVID-19.
Methods: In this study, venous blood samples were taken from patients who were requested to have COVID-19 antibodies from our hospital's outpatient clinics between February 2022 and March 2022.
Results: There was no statistically significant difference when IgG antibody positivity was compared according to the age ranges in chemiluminescence and immunochromatographic methods. When patients were evaluated according to antibody titers, it was found that 81% of the seronegative patients were unvaccinated and had not had Covid-19, and it was found that this group was statistically significant compared to other groups.
Conclusions: It has been concluded that it will be of great importance for every country, even every region, to have a test and vaccine policy for diagnosis and follow-up in the fight against COVID-19.
Metrics
References
Poland G, Ovsyannikova I, Kennedey R. SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. Lancet. 2020;396(10262):1595-606
Bahceci I, Yildiz IE, Duran OF, Soztanaci US, Kirdi Harbawi Z, Senol FF, et al. Secondary Bacterial Infection Rates Among Patients With COVID-19. Cureus. 2022;14(2):4-11.
Senol FF, Bahceci I, Arslan N, Aytac O, Oner P, Ascı Toraman Z. Comparison of respiratory tract pathogens and antibiotic susceptibility profiles of patients diagnosed with COVID-19 with pre-COVID-19. J Heal Sci Med. 2022;5(2):510-6.
Senol FF, Bahceci I, Algul S. Association of IgE elevation with blood group in COVID-19 patients. J Heal Sci Med. 2022;5(4):1092-6.
Van Boheemen S, De Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio. 2012;3(6):e00473-12.
Esen Yildiz I, Bahceci I, Bagin U, Gürlek B, Duran O, Kostakoglu U, Erturk A. COVID-19 infection in pregnancy: A single-center experience in Rize in the Eastern Black Sea Region. Ann Clin Anal Med. 2022;13(2):141-5.
Bahceci I, Senol F. Post-vaccination COVID-19 positivity and clinical situation analysis in healthcare professionals. Ann Clin Anal Med. 2022;13(9):959-62.
Kazancıoglu L, Erdivanlı B, Kazdal H, Ozdemir A, Koyuncu T, Hızal A, et al. Effectiveness of laboratory parameters as morbidity and mortality indicators in patients with coronavirus disease-2019 admitted to the intensive care Unit. Turkish J Intensive Care. 2021;19:33-43.
Patel R, Babady E, Theel ES, Storch GA, Pinsky BA, St. George K, et al. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: value of diagnostic testing for SARS-CoV-2/COVID-19. MBio. 2020;11(2):e00722-20.
Tan CW, Chia WN, Qin X, Liu P, Chen MIC, Tiu C, et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction. Nat Biotechnol. 2020;38(9):1073-8.
Zhong L, Chuan J, Gong B, Shuai P, Zhou Y, Zhang Y, et al. Detection of serum IgM and IgG for COVID-19 diagnosis. Sci China Life Sci. 2020;63:777-80.
Vashist SK. In vitro diagnostic assays for COVID-19: recent advances and emerging trends. Diagnostics. 2020;10(4):202.
Lu H, Stratton CW, Tang YW. An evolving approach to the laboratory assessment of COVID-19. J Med Virol. 2020;92(10):1812-7.
Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for SARS-CoV-2. JAMA - J Am Med Assoc. 2020;323(22):2249-51.
World Health Organization. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases. 2020. Available at: https://apps.who.int/iris/bitstream/handle/10665/331501/WHOCOVID-19-laboratory-2020.5eng.pdf?sequence=1. Accessed 18 Feb 2023.
Yan Y, Chang L, Wang L. Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures. Rev Med Virol. 2020;30(3):1-14.
Qiu M, Shi Y, Guo Z, Chen Z, He R, Chen R, et al. Antibody responses to individual proteins of SARS coronavirus and their neutralization activities. Microbes Infect. 2005;7(5-6):882-9.
Zhang W, Du R, Li B, Zheng X, Lou Yang Z, Hu B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):1-4.
Quesada-González D, Merkoçi A. Nanoparticle-based lateral flow biosensors. Biosens Bioelectron. 2015;73:47-63.
Posthuma-Trumpie GA, Korf J, Van Amerongen A. Lateral flow (immuno) assay: Its strengths, weaknesses, opportunities and threats. A literature survey. Anal Bioanal Chem. 2009;393(2):569-82.
Wang M, Wu Q, Xu W, Qiao B, Wang J, Jiang S, et al. Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan. MedRxiv. 2020:1-18.
Wang C, Wu Z, Liu B, Zhang P, Lu J, Li J, et al. Track-etched membrane microplate and smartphone immunosensing for SARS-CoV-2 neutralizing antibody. Biosensors. 2021;192:1-11.
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603-15.
Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Freedman L, Haas EJ, et al. Waning Immunity after the BNT162b2 Vaccine in Israel. N Engl J Med. 2021;385(24):e85.
Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, et al. Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months. N Engl J Med. 2021;385(24):e84.
Tartof S, Slezak J, Fischer H, Hong V, Ackerson B, Ranasinghe O, et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. 2021;398(10309):1407-16.
Metsky HC, Freije CA, Kosoko-Thoroddsen TSF, Sabeti PC, Myhrvold C. CRISPR-based surveillance for COVID-19 using genomically-comprehensive machine learning design. BioRxiv. 2020:1-11.
Cheng MP, Yansouni CP, Basta NE, Desjardins M, Kanjilal S, Paquette K, et al. Serodiagnostics for severe acute respiratory syndrome-related Coronavirus 2: A narrative review. Ann Intern Med. 2020;173(6):450-60.
Liu W, Liu L, Kou G, Zheng Y, Ding Y, Ni W, et al. Evaluation of nucleocapsid and spike protein-based enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2. J Clin Microbiol. 2020;58(6):1-7.
Candel González FJ, Viñuela-Prieto JM, Del Castillo JG, García PB, Saavedra MF, Píriz AH, et al. Utility of lateral flow tests in SARS-CoV-2 infection monitorization. Rev Esp Quimioter. 2020;33(4):258–66.
Şirin MC, Sesli Çetin E, Aridoğan B. Microbiological diagnosis of SARS-CoV-2 infection. SDÜ Med Facul J. 2021;28:137-45.
Zavaglio F, Cassaniti I, Sammartino JC, Tonello S, Sainaghi PP, Novelli V, et al. mRNA BNT162b vaccine elicited higher antibody and CD4+ T-Cell responses than patients with mild COVID-19. Microorganisms. 2022;10(6):1250.
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. SSRN Electron J. 2020;71(15):762-8.
Rovida F, Cassaniti I, Paolucci S, Percivalle E, Sarasini A, Piralla A, et al. SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers. Nat Commun. 2021;12(1):1-7.
Lustig Y, Sapir E, Regev-Yochay G, Fluss C, Olmer L, Indenbaum V, et al. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lancet Respir Med. 2021;9(9):999-1009.
Bates T, Leier H, Goodman J, Curlin M, Messer W, Tafesse F. Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples. JAMA. 2021;326(9):868-9.
Vural P, HACIBEKİROĞLU M, YILDIZ FR, VURAL P. Post-vaccination immunological response in a group of health workers who have and has not had COVID-19 in the pandemic. ANKEM Derg. 2021;35(2):45-52.
38. Hörber S, Soldo J, Relker L, Jürgens S, Guther J, Peter S, Lehmann R, Peter A. Evaluation of three fully-automated SARS-CoV-2 antibody assays. Clin Chem Lab Med. 2020;58:2113–20
Mazzoni A, Vanni A, Spinicci M, Lamacchia G, Kiros ST, Rocca A, et al. SARS-CoV-2 infection and vaccination trigger longlived B and CD4+ T lymphocytes with implications for booster strategies. J Clin Invest. 2022;132(6):1-12.
Downloads
Published
How to Cite
Issue
Section
